lets go pno we need a cruise, page-6

It will be a disappointing quarterly Im sure. But not an unexpected one. The saving grace will be that PNO has given no guidence, so the market wont savage poor numbers.

You know from INT what can happen if you miss forcasts. Sometimes you'd be better off not making any forecasts. Thats been PNOs approach and it should insulate the sp if revenues are still low. And how could they not be low with the lack of chemists stocking it and no marketing.

Definately most are in this for the possibility of the pain patch connection with OBJ or any significant licensing deal. Thermalife is just something to amuse us while we wait.